AI assistant
Mankind Pharma Limited — Call Transcript 2026
May 8, 2026
61869_rns_2026-05-08_d59c8675-d140-4a2a-9d09-235c3bf25605.pdf
Call Transcript
Open in viewerOpens in your device viewer
M
Mankind
Serving Life
May 08, 2026
BSE Limited
P J Towers,
Dalal Street,
Mumbai – 400 001
Scrip Code: 543904
National Stock Exchange of India Limited
Exchange Plaza, C-1, Block G,
Bandra Kurla Complex,
Bandra (E), Mumbai – 400 051
Symbol: MANKIND
Dear Sir/ Madam,
Subject: Intimation of Investor Conference Call for Q4FY26 & FY26 with Senior Management of Mankind Pharma Limited (“the Company”)
Pursuant to Regulation 30 & 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Company will host Investor Conference Call on Wednesday, May 20, 2026 at 12:00 PM (IST) for Q4FY26 and FY26.
Details of the Investor Conference Call are enclosed herewith.
The same are also being uploaded on website of the Company at www.mankindpharma.com.
You are requested to kindly take the same on records.
Thanking You,
Yours Faithfully,
For Mankind Pharma Limited
HITESH
KUMAR
JAIN
Digitally signed by
HITESH KUMAR JAIN
Date: 2026.05.08
19:11:50 +05'00'
Hitesh Kumar Jain
Company Secretary &
Compliance Officer
Encl.: A/a
MANKIND PHARMA LIMITED
Regd. Office : 208, Okhla Ind. Estate, Phase - 3, New Delhi-110020 • Ph. : 011-46846700, 47476600
CIN No. L74899DL1991 PLC044843 • E-mail : [email protected] • www.mankindpharma.com
M
Mankind
Serving Life
Mankind Pharma Limited
Earnings Call Invite | Q4 & FY26
You are cordially invited to the Earnings Call,
Scheduled on Wednesday, 20th May 2026, at 12:00 PM IST,
To discuss Q4 & FY26 business performance and results:
The details of the earnings call are as below:
| Earnings Call Details | |
|---|---|
| Date | Wednesday, 20th May 2026 |
| Time | 12:00 PM – 01:00 PM IST |
| Zoom Call | https://us06web.zoom.us/webinar/register/WN_gjCF6TrYR9eK24zP-RYSZQ |
Management will be represented by:
- Mr. Rajeev Juneja – Vice Chairman & Managing Director
- Mr. Sheetal Arora – Chief Executive Officer & Whole Time Director
- Mr. Arjun Juneja – Chief Operating Officer
- Mr. Sudipta Roy – Senior President – Sales & Marketing
- Mr. Ashutosh Dhawan – Global Chief Financial Officer
- Mr. Prakash Agarwal – President (Strategy)
- Mr. Abhishek Agarwal – Head - Investor Relations & Strategy
For details, please contact:
| Mankind Pharma Limited Abhishek Agarwal E: [email protected], T: 011 – 46846700 | Adfactors PR Snighter Albuquerque / Smit Shah E: [email protected] / [email protected], M: +91 9870789596 |
|---|---|